MB-102 (Relmapirazin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MB-102 (Relmapirazin), covering 2025-03-28 to 2025-03-28. Get the full timeline:
Most recent: Clinical Trial Update: Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring [Phase 3]